Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective
Yasamin Davatgaran-Taghipour,1,2 Salar Masoomzadeh,3 Mohammad Hosein Farzaei,4,5 Roodabeh Bahramsoltani,6 Zahra Karimi-Soureh,7 Roja Rahimi,6,8 Mohammad Abdollahi9,10 1Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, I...
Guardado en:
Autores principales: | Davatgaran-Taghipour Y, Masoomzadeh S, Farzaei MH, Bahramsoltani R, Karimi-Soureh Z, Rahimi R, Abdollahi M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/45ca251fab1643b8a010865dfbf2a62b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanoformulations of natural products for management of metabolic syndrome
por: Taghipour YD, et al.
Publicado: (2019) -
Current Advances in the Use of Nanophytomedicine Therapies for Human Cardiovascular Diseases
por: Hesari M, et al.
Publicado: (2021) -
Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy
por: Ramsha Aamir, et al.
Publicado: (2021) -
Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction
por: Qi Q, et al.
Publicado: (2017) -
A dual-targeted multifunctional nanoformulation for potential prevention and therapy of Alzheimer's disease
por: Dongju Zhao, et al.
Publicado: (2021)